Positive residues of the SARS-CoV-2 fusion domain are key contributors to the initiation of membrane fusion.

Positive residues of the SARS-CoV-2 fusion domain are key contributors to the initiation of membrane fusion.

Publication date: Jul 11, 2024

SARS-CoV-2 is one of the most infectious viruses ever recorded. Despite a plethora of research over the last several years, the viral lifecycle is still not well understood, particularly membrane fusion. This process is initiated by the fusion domain (FD), a highly conserved stretch of amino acids consisting of a fusion peptide (FP) and fusion loop (FL), which in synergy perturbs the target cells lipid membrane to lower the energetic cost necessary for fusion. In this study, through a mutagenesis-based approach, we have investigated the basic residues within the FD (K825, K835, R847, K854) utilizing an in vitro fusion assay and F NMR, validated by traditional C N techniques. Alanine and charge conserving mutants revealed every basic residue plays a highly specific role within the mechanism of initiating fusion. Intriguingly, K825A led to increased fusogenecity which was found to be correlated to the number of amino acids within helix one, further implicating the role of this specific helix within the FD’s fusion mechanism. This work has found basic residues to be important within the FDs fusion mechanism and highlights K825A, a specific mutation made within the FD of the SARS-CoV-2 spike protein, as requiring further investigation due to its potential to contribute to a more virulent strain of SARS-CoV-2.

Concepts Keywords
Implicating (19)F NMR
Lipid Electrostatics
Mutants Lipidā€Protein Interaction
Viral Membrane Fusion
Years Membrane Lipid
Mutagenesis
SARS-CoV-2
Virus Entry

Semantics

Type Source Name
disease VO Viruses
disease IDO process
drug DRUGBANK Amino acids
disease IDO assay
drug DRUGBANK L-Alanine

Original Article

(Visited 1 times, 1 visits today)